Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microorganisms Identified by Microbial Detection Array in 24 Hours

By LabMedica International staff writers
Posted on 12 May 2010
A microbial detection array provides scientists with the capability of identifying pathogens over the entire range of known viruses and bacteria.

The array detects microorganisms with the use of 388,000 probes that fit in a checkerboard pattern in the middle of a 2.54-cm wide, 7.62-cm long glass slide. More...
It will be useful for medical professionals diagnosing diseases, regulatory agencies checking product safety, and law enforcement authorities seeking to detect bioterrorism attacks.

The current operational version of the Lawrence Livermore National Laboratory (LLMD; Livermore, CA, USA) detection array (LLMDA) contains probes that can detect more than 2,000 viruses and about 900 bacteria. Scientists will be able to detect all known bacterial and viral pathogens in comparison to current multiplex polymerase chain reaction (PCR) techniques that can at best offer detection from among 50 organisms in one test.

In an online article on April 7, 2010, in the Journal of Virology, Livermore investigators working with a scientist from the Blood Systems Research Institute (San Francisco, CA, USA) said that they used the LLMDA technology to confirm the presence of an apparently benign pig virus in a vaccine. The pig virus, porcine circovirus-1 (PCV-1), was unexpectedly found in GlaxoSmithKline's (Brentford, UK) Rotarix vaccine, which is used to prevent diarrhea in babies.

"The ability to detect the major bacterial and viral components of any sample can be used in countless different ways," said Tom Slezak, LLNL's associate program leader for Informatics. "This is important because it fills a cost-performance gap that is relevant to many missions: biodefense, public health, and product safety."

Related Links:

Lawrence Livermore National Laboratory
Blood Systems Research Institute
GlaxoSmithKline




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.